Answer
Elocta (efmoroctocog alfa) treats and prevents bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency).
Sources for this answer
- ELOCTA 250 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated
Sources checked